Pharmacological pallidotomy with glutamate antagonists

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.

Human molecular genetics·2017

LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.

Free radical research·2015

Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Neurobiology of disease·2014

Gene-environment interactions in Parkinson's disease: the importance of animal modeling.

Clinical pharmacology and therapeutics·2010

Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.

Neuroscience·2008

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

Neurology·2005

Cross-Sectional and Longitudinal Diagnostic Performance of Plasma p-tau217 and p-tau217/Aβ42 in Alzheimer's Disease.

Annals of neurology·2026

Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.

Annals of neurology·2026

Outcomes of Intra-Arterial Tenecteplase after Endovascular Reperfusion for Acute Ischemic Stroke Due to Cardioembolism and Non-Cardioembolism: A Secondary Analysis of the POST-TNK Trial.

Annals of neurology·2026

A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation.

Annals of neurology·2026

Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk.

Annals of neurology·2026

Establishing Sensory Neurons as Therapeutic Targets in Peripheral Neuropathy Driven by Polyglutamine Expanded Murine ATXN3.

Annals of neurology·2026

The Combination of Buprenorphine and Pregabalin in the Management of Peripheral Neuropathic Pain: A Phase IV, Randomized, Double-Blind and Placebo-Controlled Clinical Trial.

European journal of pain (London, England)·2026

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

Journal of clinical pharmacology·2026

A Survey of the Use of Bolus Subcutaneous Injection of Pantoprazole in Palliative Care.

Journal of palliative medicine·2026

An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine.

Current pain and headache reports·2026

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Toxicology reports·2026

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

American journal of physiology. Regulatory, integrative and comparative physiology·2026

Related Experiment Videos

Pharmacological pallidotomy with glutamate antagonists

Related Concept Videos

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.

LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.

Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Gene-environment interactions in Parkinson's disease: the importance of animal modeling.

Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

Cross-Sectional and Longitudinal Diagnostic Performance of Plasma p-tau217 and p-tau217/Aβ42 in Alzheimer's Disease.

Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.

Outcomes of Intra-Arterial Tenecteplase after Endovascular Reperfusion for Acute Ischemic Stroke Due to Cardioembolism and Non-Cardioembolism: A Secondary Analysis of the POST-TNK Trial.

A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation.

Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk.

Establishing Sensory Neurons as Therapeutic Targets in Peripheral Neuropathy Driven by Polyglutamine Expanded Murine ATXN3.

The Combination of Buprenorphine and Pregabalin in the Management of Peripheral Neuropathic Pain: A Phase IV, Randomized, Double-Blind and Placebo-Controlled Clinical Trial.

Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First-in-Human Single- and Multiple-Ascending Dose Study in Healthy Male Volunteers.

A Survey of the Use of Bolus Subcutaneous Injection of Pantoprazole in Palliative Care.

An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine.

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

Related Experiment Videos

Pharmacological pallidotomy with glutamate antagonists

Related Concept Videos

Related Articles